BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37603945)

  • 21. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
    Liu S; Yan G; Zhang J; Yu L
    Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach.
    Amer HT; Eissa RA; El Tayebi HM
    Front Mol Biosci; 2022; 9():1032517. PubMed ID: 36387279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
    Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
    Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer.
    Yu J; Jin T; Zhang T
    Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
    Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
    Gutschner T; Hämmerle M; Eissmann M; Hsu J; Kim Y; Hung G; Revenko A; Arun G; Stentrup M; Gross M; Zörnig M; MacLeod AR; Spector DL; Diederichs S
    Cancer Res; 2013 Feb; 73(3):1180-9. PubMed ID: 23243023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
    Liu Y; Gao S; Du Q; Zhao Q
    Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
    Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
    Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
    Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
    Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer.
    Ou X; Gao G; Bazhabayi M; Zhang K; Liu F; Xiao X
    J Cancer Res Ther; 2019; 15(7):1597-1602. PubMed ID: 31939443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos.
    Lin J; Hu Y; Zhao JJ
    J Vis Exp; 2018 Dec; (142):. PubMed ID: 30596388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
    Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
    Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
    Amodio N; Stamato MA; Juli G; Morelli E; Fulciniti M; Manzoni M; Taiana E; Agnelli L; Cantafio MEG; Romeo E; Raimondi L; Caracciolo D; Zuccalà V; Rossi M; Neri A; Munshi NC; Tagliaferri P; Tassone P
    Leukemia; 2018 Sep; 32(9):1948-1957. PubMed ID: 29487387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
    Monterroza L; Parrilla MM; Samaranayake SG; Rivera-Rodriguez DE; Yoon SB; Bommireddy R; Hosten J; Barragan LC; Marcus A; Dobosh BS; Selvaraj P; Tirouvanziam R
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.